SCHEMBL15436240

SCHEMBL15436240

O=C(Nc1ccccc1)Nc1cc(Nc2ccccc2)ncn1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 8/20 0.62
▸ ERBB3 P21860 5/20 0.62
▸ CASP3 P42574 1/20 0.58
▸ SENP7 Q9BQF6 1/20 0.58
▸ NPC1 O15118 3/20 0.57
▸ RAB9A P51151 3/20 0.57
▸ SMN1; SMN2 Q16637 2/20 0.57
▸ ADORA3 P0DMS8 2/20 0.57
▸ PIM1 P11309 1/20 0.57
▸ ADORA2A P29274 1/20 0.57
▸ ADORA2B P29275 1/20 0.57
▸ ADORA1 P30542 1/20 0.57
▸ FLT3 P36888 1/20 0.57
▸ PIM3 Q86V86 1/20 0.57
▸ AURKB Q96GD4 1/20 0.57
▸ TP53 P04637 1/20 0.55
▸ EPHX1 P07099 1/20 0.55
▸ TSHR P16473 1/20 0.55
▸ EPHX2 P34913 1/20 0.55
▸ CDK9 P50750 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL374604 0.89 MEN1 (0.66) EGFRERBB3NPC1RAB9AKMT2A
SCHEMBL1518723 0.83 CNR1 (0.69) EGFRCASP3SENP7NPC1RAB9A
SCHEMBL414719 0.82 MEN1 (0.70) EGFRERBB3NPC1RAB9ATP53
SCHEMBL374798 0.82 MEN1 (0.66) EGFRERBB3NPC1RAB9AKMT2A
SCHEMBL373375 0.82 MEN1 (0.60) EGFRERBB3NPC1RAB9ASMN1; SMN2
SCHEMBL1897213 0.81 KDR (0.80) TNNI3KKDR
SCHEMBL3226154 0.79 S1PR1 (0.61) EGFRERBB3NPC1RAB9ASMN1; SMN2
SCHEMBL691538 0.77 EGFR (0.79) EGFRERBB3JAK3
SCHEMBL25387375 0.77 KMO (0.54) EGFRERBB3NPC1RAB9ATP53
SCHEMBL3226900 0.77 KMO (0.66) EGFRERBB3NPC1RAB9AAURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2394999-B1 AMINOPYRAZINE DERIVATIVE AND MEDICINE NIPPON SHINYAKU CO LTD (JP) 2014-01-29 — — EP disclosed
Send feedback